What Is a Goblet Cell and What Is Its Function?

A goblet cell is a specialized mucus-producing cell found in the lining of the intestines, airways, and the surface of the eye. Its primary job is to secrete thick, gel-like mucins that form a protective barrier between the body’s delicate tissues and the outside world. The name comes from the cell’s shape: narrow at the base and bulging at the top where mucus granules accumulate, resembling a drinking goblet. Though their mucus-secreting role has been understood for well over a century, researchers have only recently discovered that goblet cells do far more than coat surfaces in slime.

Where Goblet Cells Live

Goblet cells are scattered among the ordinary lining cells of several organs, always positioned where the body meets some external environment. The largest populations sit in the intestinal tract, where they are woven throughout the epithelium from the stomach all the way to the rectum. Their density increases as you move down the gut: relatively sparse in the small intestine, they become much more abundant in the colon, where the microbial load is heaviest and the need for a robust mucus barrier is greatest.

In the respiratory system, goblet cells line the airways from the nose down through the bronchi. Alongside submucosal glands deeper in the airway wall, they produce the sticky mucus layer that traps inhaled particles, bacteria, and pollutants so that cilia can sweep them back up and out of the lungs.¹ The eye has its own population too. Conjunctival goblet cells sit in the thin membrane covering the white of the eye and the inner eyelids, where they release soluble mucins into the tear film to keep the ocular surface lubricated and protected.²

What Goblet Cells Produce

The star products of goblet cells are mucins, which are large proteins decorated with chains of sugar molecules. These sugar chains make mucins intensely water-attracting, which is why mucus has its characteristic wet, gel-like consistency. Different goblet cells in different organs produce different mucins tailored to local needs. In the intestine, the dominant mucin is called MUC2. In the stomach and airways, MUC5AC takes center stage.³

Intestinal goblet cells do not just release MUC2 and call it a day. They also secrete a suite of accessory molecules, including proteins like TFF3 (which helps repair damaged tissue) and others that contribute to the mucus layer’s structural integrity and antimicrobial properties.³ The mucins themselves link together to form a vast, net-like polymer that gives the mucus layer its physical structure rather than being a simple coating of goo.⁴

The Two-Layer System in the Colon

One of the more surprising findings about goblet cell output is how differently the mucus is organized depending on where you are in the gut. In the small intestine, there is only a single, relatively loose mucus layer. In the colon, however, goblet cells build a two-layer mucus system. The inner layer sits firmly attached to the epithelial surface and is dense enough that bacteria essentially cannot penetrate it. The outer layer is looser and serves as a habitat where certain gut bacteria can live and interact with the host.⁵

This two-layer architecture is not just a curiosity. It represents a carefully maintained compromise: keeping bacteria at a safe distance from the vulnerable cell layer beneath while still allowing the microbiome to thrive close enough to carry out its beneficial roles. When this system breaks down, bacteria contact the epithelium directly, and inflammation often follows.

How Goblet Cells Help Train the Immune System

For decades, goblet cells were understood as passive mucus factories. That picture has changed dramatically. Researchers have discovered that goblet cells in the intestine form structures called goblet cell-associated antigen passages, or GAPs. These passages allow small samples of material from the gut lumen, including bits of food protein and bacterial components, to be shuttled through the goblet cell and delivered to immune cells waiting just beneath the epithelial surface.⁶

This is a form of controlled sampling. By presenting harmless antigens to immune cells in a calm, non-inflammatory context, GAPs help the immune system learn what is safe and what deserves a response. Studies have found that GAPs, rather than other pathways for capturing material from the gut, correlated with the ability of immune cells in the tissue to acquire luminal substances and with the places where the body develops tolerance to dietary and bacterial antigens.⁷ In other words, goblet cells play an active gatekeeping role in preventing your immune system from overreacting to the food you eat or the normal bacteria in your gut. When this process fails, it can contribute to food allergies and intestinal inflammation.⁶

How Goblet Cells Develop

Goblet cells are not permanent residents. Like other cells lining the intestine, they are constantly being replaced. They originate from intestinal stem cells located in the base of tiny pits in the gut lining called crypts. As these stem cells divide, their daughter cells can become absorptive cells (the default) or secretory cells like goblet cells, Paneth cells, or hormone-producing cells. The decision hinges on a signaling system called Notch. When Notch signaling is active, cells tend to become absorptive. When it is dialed down, cells are pushed toward a secretory fate, including the goblet cell lineage.⁸

This Notch-based switch matters beyond basic biology. Conditions that alter Notch signaling can shift the balance of cell types in the gut lining. For example, research has shown that systemic iron overload can inhibit Notch signaling and push stem cells toward goblet cell differentiation, effectively changing the composition of the intestinal lining.⁹ This illustrates how sensitive the goblet cell population is to signals from the broader body, not just local cues in the gut.

What Happens When Goblet Cells Fail in the Gut

Mucin production is biochemically demanding work. MUC2, the main intestinal mucin, is an enormous molecule that must be properly folded and assembled inside the goblet cell’s endoplasmic reticulum before it can be packaged and secreted. When this folding process goes wrong, misfolded MUC2 accumulates inside the cell and triggers a stress response. Studies in mice have shown that faulty mucin assembly causes endoplasmic reticulum stress in goblet cells, activation of stress-response pathways, and spontaneous intestinal inflammation that resembles ulcerative colitis.¹⁰ Similar signs of misfolded MUC2 and cellular stress have been found in human ulcerative colitis tissue, even in patches that are not actively inflamed.¹⁰

During active intestinal inflammation, the problem can feed itself in a vicious cycle. When the gut is inflamed, goblet cells ramp up MUC2 production to try to rebuild the protective mucus barrier. But that surge in production increases the chances of protein misfolding, which triggers more stress and can lead to goblet cell death. The result is that the very cells responsible for defending the barrier end up destroying themselves, leaving the epithelium exposed and worsening the disease.¹¹ Research into inflammatory bowel disease increasingly points to the inability to properly manage this cellular stress in highly secretory cells like goblet cells as both a potential initiator and a perpetuator of chronic inflammation.¹²

Goblet Cell Hyperplasia in the Airways

While the gut tends to suffer from goblet cell depletion during disease, the airways often face the opposite problem: too many goblet cells. In conditions like asthma and chronic obstructive pulmonary disease, chronic inflammation drives the airway lining to produce an excess of goblet cells, a process called goblet cell hyperplasia. The result is excessive, thick mucus that clogs the airways and makes breathing difficult.

The inflammatory signals that drive this overgrowth have been gradually worked out. Key culprits include cytokines like IL-13 and IL-9, along with other inflammatory mediators. IL-13 in particular has been shown to increase production of MUC5AC, the primary airway mucin, in bronchial epithelial cells.¹³ Other inflammatory molecules, including TNF-alpha and certain prostaglandin-pathway enzymes, also contribute to the upregulation of mucin production and the expansion of the goblet cell population.¹⁴

Understanding these pathways has opened the door to new drug targets. Rather than just treating symptoms with bronchodilators or steroids, researchers are investigating therapies that block the specific signaling cascades leading to goblet cell overproduction. Biologics that neutralize IL-13 are already in clinical use for severe asthma, and they owe their rationale in part to the recognition that goblet cell hyperplasia is a central feature of the disease, not just a side effect.

Goblet Cell Loss and Dry Eye

In the eye, goblet cell problems manifest as loss rather than overgrowth. The conjunctival goblet cells that supply mucins to the tear film are vulnerable to inflammatory damage, and their decline is a hallmark of several forms of dry eye disease. Conditions like Sjögren syndrome, Stevens-Johnson syndrome, and graft-versus-host disease are all associated with goblet cell loss on the ocular surface, and the severity of that loss tends to track with the clinical severity of the eye disease.¹⁵

A key driver of this damage is a cytokine called IFN-gamma, produced by certain immune cells. IFN-gamma disrupts goblet cell secretion, triggers a stress response inside the cells, and ultimately kills them. Animal studies have confirmed that suppressing IFN-gamma and related immune mediators can increase goblet cell density on the ocular surface, suggesting a potential therapeutic angle for restoring the tear film in dry eye patients.¹⁵ This connection between goblet cell health and dry eye is practical knowledge: if you have an autoimmune condition or chronic eye inflammation, your goblet cells may be quietly declining, which accelerates tear film instability and surface damage. Goblet cell counts on the conjunctiva can even serve as an early biomarker for ocular surface disease in conditions like rheumatoid arthritis, where patients showed lower goblet cell counts even when dry eye was not yet their primary complaint.¹⁶

Goblet Cells and Barrett’s Esophagus

Goblet cells normally do not belong in the esophagus. The esophageal lining is made of a different cell type altogether, a flat, layered squamous epithelium. When chronic acid reflux repeatedly damages the lower esophagus, however, the tissue can undergo a transformation called intestinal metaplasia, in which it is replaced by intestinal-type cells, including goblet cells. This condition is known as Barrett’s esophagus and is considered a precursor to esophageal adenocarcinoma.

The appearance of goblet cells in biopsies has traditionally been the defining diagnostic feature of Barrett’s esophagus, particularly in the United States. But the reliance on goblet cells as a marker has come under scrutiny. The non-goblet cells in the same metaplastic tissue often carry the same molecular abnormalities that goblet cells do, and goblet cells fluctuate over time. They can even decrease in number as the tissue progresses toward cancer, which makes them an unreliable gauge of disease severity.¹⁷ Pathologists also have difficulty reliably distinguishing true goblet cells from other mucus-producing cell types in the esophagus. This has led to debate about whether requiring goblet cells for a Barrett’s diagnosis is the right approach, since the surrounding tissue may already be biologically “intestinalized” regardless of whether goblet cells happen to be captured in a biopsy sample.¹⁷

Organoid Research and Future Directions

Much of the recent progress in understanding goblet cells has been enabled by organoid technology. Organoids are miniature, three-dimensional structures grown from stem cells in a lab dish that mimic the architecture and cell composition of real organs. Researchers can now grow thousands of tiny gut organoids and screen them with different drugs or genetic manipulations to see how the balance between cell types, including goblet cells, shifts in response.¹⁸

This kind of high-throughput approach is accelerating the search for drugs that can either boost goblet cell numbers when they are depleted (as in inflammatory bowel disease or dry eye) or rein them in when they proliferate excessively (as in asthma). Because organoid screens can track how thousands of compounds affect stem cell differentiation in parallel, they compress years of traditional experimentation into months. The conjunctival side has its own regenerative angle, with researchers exploring whether goblet cells lost to autoimmune conditions can be coaxed to regenerate through targeted suppression of the immune signals that killed them off.²

What makes goblet cell research compelling, beyond its practical applications, is how it illustrates a broader theme in biology: cells that were once filed away as simple, single-purpose workers turn out to be sophisticated participants in immune regulation, barrier maintenance, and even disease initiation. The mucus they produce is not passive wallpaper. It is a dynamic, structured material that the body continuously remodels in response to diet, infection, inflammation, and microbial signals. Getting goblet cells right, in the right numbers, producing the right mucins, in the right configuration, turns out to be one of the body’s more demanding balancing acts.

1
European Respiratory Journal. Airway goblet cells: responsive and adaptable front-line defenders
2
PubMed Central. Conjunctival goblet cells: Ocular surface functions, disorders that affect them, and the potential for their regeneration
3
PubMed Central. The mucus and mucins of the goblet cells and enterocytes provide the first defense line of the gastrointestinal tract and interact with the immune system
4
PubMed Central. The two mucus layers of colon are organized by the MUC2 mucin, whereas the outer layer is a legislator of host-microbial interactions
5
PubMed Central. Composition and functional role of the mucus layers in the intestine
6
PubMed. Goblet cell-associated antigen passage: A gatekeeper of the intestinal immune system
7
PubMed Central. Goblet Cell Associated Antigen Passages Support the Induction and Maintenance of Oral Tolerance
8
PubMed Central. Notch signaling modulates proliferation and differentiation of intestinal crypt base columnar stem cells
9
PubMed Central. Differentiation of intestinal stem cells toward goblet cells under systemic iron overload stress are associated with inhibition of Notch signaling pathway and ferroptosis
10
PLoS Medicine. Aberrant Mucin Assembly in Mice Causes Endoplasmic Reticulum Stress and Spontaneous Inflammation Resembling Ulcerative Colitis
11
PubMed. High MUC2 Mucin Expression and Misfolding Induce Cellular Stress, Reactive Oxygen Production, and Apoptosis in Goblet Cells
12
PubMed Central. Endoplasmic reticulum stress in the intestinal epithelium and inflammatory bowel disease
13
PubMed. HO-1 inhibits IL-13-induced goblet cell hyperplasia associated with CLCA1 suppression in normal human bronchial epithelial cells
14
PubMed. New pharmacotherapy for airway mucus hypersecretion in asthma and COPD: targeting intracellular signaling pathways
15
PubMed Central. Immune – Goblet Cell Interaction in the Conjunctiva
16
Scientific Reports. Dry eye in rheumatoid arthritis patients under TNF-inhibitors: conjunctival goblet cell as an early ocular biomarker
17
PubMed. Histology of Barrett’s Metaplasia: Do Goblet Cells Matter?
18
Nature Biomedical Engineering. Screening for modulators of the cellular composition of gut epithelia via organoid models of intestinal stem cell differentiation